The adaptive response to iron scarcity is the overexpression of TfR, observed in breast cancer experiments [76, 77], and previously used to increase the uptake of transferrin conjugates in vitro in glioma or leukemia cells [22, 85, 91]. The gene discussed is TFRC; the disease is leukemia.